BURNABY, British Columbia (AP) _ Arbutus Biopharma Corp. (ABUS) on Monday reported a loss of $23.3 million in its first quarter.
On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 47 cents.
The biopharmaceutical company posted revenue of $700,000 in the period.
In the final minutes of trading on Monday, the company's shares hit $2.65. A year ago, they were trading at $5.90.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABUS at https://www.zacks.com/ap/ABUS